(Q39150971)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23680920%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

title

Distribution of the anticancer drugs doxorubicin, mitoxantrone and topotecan in tumors and normal tissues (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23680920%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

1 reference

Krupa J Patel

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23680920%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

publication date

17 May 2013

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23680920%20AND%20SRC:MED&resulttype=core&format=json

Cancer Chemotherapy and Pharmacology

1 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23680920%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

volume

72

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23680920%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23680920%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

page(s)

127-138

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23680920%20AND%20SRC:MED&resulttype=core&format=json

A phase II trial of continuous-infusion 6-mercaptopurine for childhood solid tumors

1 March 2020

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00280-013-2176-Z

Selective ablation of immature blood vessels in established human tumors follows vascular endothelial growth factor withdrawal

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-013-2176-Z

Angiogenesis in cancer and other diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-013-2176-Z

Efficacy and toxicity profile of oral topotecan in a panel of human tumour xenografts

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-013-2176-Z

Determination of topotecan in human and mouse plasma and in mouse tissue homogenates by reversed-phase high-performance liquid chromatography

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-013-2176-Z

Mitoxantrone. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in the chemotherapy of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-013-2176-Z

A critical evaluation of the mechanisms of action proposed for the antitumor effects of the anthracycline antibiotics adriamycin and daunorubicin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-013-2176-Z

Recurrent epithelial ovarian carcinoma: a randomized phase III study of pegylated liposomal doxorubicin versus topotecan

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-013-2176-Z

The penetration of anticancer drugs through tumor tissue as a function of cellular adhesion and packing density of tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-013-2176-Z

Doxorubicin pharmacokinetics: Macromolecule binding, metabolism, and excretion in the context of a physiologic model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-013-2176-Z

Openings between defective endothelial cells explain tumor vessel leakiness

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-013-2176-Z

Evaluation of mitoxantrone for the treatment of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-013-2176-Z

Improved liquid chromatographic method for mitoxantrone quantification in mouse plasma and tissues to study the pharmacokinetics of a liposome entrapped mitoxantrone formulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-013-2176-Z

DNA topoisomerase poisons as antitumor drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-013-2176-Z

Penetration and binding of vinblastine and 5-fluorouracil in cellular spheroids.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-013-2176-Z

The distribution of the anticancer drug Doxorubicin in relation to blood vessels in solid tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-013-2176-Z

Comparative pharmacokinetic and cytotoxic analysis of three different formulations of mitoxantrone in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-013-2176-Z

Phase I and pharmacologic study of topotecan: a novel topoisomerase I inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-013-2176-Z

Mitoxantrone: a new anticancer drug with significant clinical activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-013-2176-Z

The pathogenesis and treatment of brain metastases: a comprehensive review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-013-2176-Z

The hypoxia-activated ProDrug AQ4N penetrates deeply in tumor tissues and complements the limited distribution of mitoxantrone.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-013-2176-Z

Sensitive high performance liquid chromatographic assay for assessment of doxorubicin pharmacokinetics in mouse plasma and tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-013-2176-Z

Topotecan versus cyclophosphamide, doxorubicin, and vincristine for the treatment of recurrent small-cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-013-2176-Z

Comparative metabolism and excretion of adriamycin in man, monkey, and rat

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-013-2176-Z

The anthracycline antineoplastic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-013-2176-Z

Time- and concentration-dependent penetration of doxorubicin in prostate tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-013-2176-Z

10.1007/S00280-013-2176-Z

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23680920%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

1 reference